BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$279.73 USD
-1.29 (-0.46%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $279.85 +0.12 (0.04%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: AMC |
3/2024 | $2.04 | 0.98% |
Earnings Summary
For their last quarter, BioRad Laboratories (BIO) reported earnings of $3.10 per share, beating the Zacks Consensus Estimate of $2.93 per share. This reflects a positive earnings surprise of 5.80%. Look out for BIO's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of $2.04 per share, reflecting a year-over-year decrease of 38.92%.
Earnings History
Price & Consensus
Zacks News for BIO
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
BIO: What are Zacks experts saying now?
Zacks Private Portfolio Services